{
    "N/R/U": "N",
    "Applicant": "Fresenius Kabi USA, LLC",
    "BLA Number": "761379",
    "Proprietary Name": "Otulfi",
    "Proper Name": "ustekinumab-aauz",
    "BLA Type": "351(k) Interchangeable",
    "Strength": "45MG/0.5ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "March 21, 2025",
    "Ref. Product Proper Name": "ustekinumab",
    "Ref. Product Proprietary Name": "Stelara",
    "Supplement Number": "2",
    "Submission Type": "Supplement",
    "License Number": "2146",
    "Product Number": "004",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}